Clinical Significance of TNFSF14/LIGHT and CD160 in Gastric Cancer and Peptic Ulcer Dyspepsia.

Mohsen KeykhosraviHossein Asgarian-OmranReza ValadanMohsen TehraniSeyed Mohammad JavadzadehSaeid TaghilooAhmad NajafiQasem FatehiIslam MajdAbolghasem Ajami

Published in: Asian Pacific journal of cancer prevention : APJCP (2024)

These findings suggest the possible role of LIGHT and CD160 expression in gastric cancer patients in immune dysregulation toward gastric cancer. Targeted immunotherapy that harnessing co-stimulatory molecules like LIGHT and CD160 could be a promising approach in the treatment of GC as well as potential GC tumor markers.

Keyphrases

poor prognosis
nk cells
cancer therapy
risk assessment
binding protein
drug delivery
machine learning
high resolution
combination therapy
helicobacter pylori infection
mass spectrometry
deep learning
climate change
smoking cessation